Insider · CIK 0001285943
James F Parslow
Files at XBIO (Xenetic Biosciences, Inc.). First filing -, latest -.
In brief
James F Parslow files SEC Form 4 as CEO and CFO at XBIO (Xenetic Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James F Parslow has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | XBIO Xenetic Biosciences, Inc. | AGrant or award Common Stock10b5-1 | +100,000 | $0.00 | $0 | 100,000 | Apr 23, 2026 |
| Dec 11, 2023 | XBIO Xenetic Biosciences, Inc. | AGrant or award Stock Optionsderivative | +10,000 | $0.00 | $0 | 10,000 | Dec 13, 2023 |
Questions about James F Parslow
Answered from the filings on this page, as of the latest one.
Is James F Parslow buying or selling?
James F Parslow has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James F Parslow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James F Parslow has 0.
Where does James F Parslow file Form 4?
James F Parslow has filed Form 4 at XBIO (Xenetic Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.